Document detail
ID

doi:10.1038/s41416-023-02209-x...

Author
Cromie, K. J. Hughes, N. F. Milner, S. Crump, P. Grinfeld, J. Jenkins, A. Norman, P. D. Picton, S. V. Stiller, C. A. Yeomanson, D. Glaser, A. W. Feltbower, R. G.
Langue
en
Editor

Nature

Category

Epidemiology

Year

2023

listing date

3/1/2023

Keywords
disparities time socio-economic cancer deprivation ethnic survival
Metrics

Abstract

Background Establishing the existence of health inequalities remains a high research and policy agenda item in the United Kingdom.

We describe ethnic and socio-economic differences in paediatric cancer survival, focusing specifically on the extent to which disparities have changed over a 20-year period.

Methods Cancer registration data for 2674 children (0–14 years) in Yorkshire were analysed.

Five-year survival estimates by ethnic group (south Asian/non-south Asian) and Townsend deprivation fifths (I–V) were compared over time (1997–2016) for leukaemia, lymphoma, central nervous system (CNS) and other solid tumours.

Hazard ratios (HR: 95% CI) from adjusted Cox models quantified the joint effect of ethnicity and deprivation on mortality risk over time, framed through causal interpretation of the deprivation coefficient.

Results Increasing deprivation was associated with significantly higher risk of death for children with leukaemia (1.11 (1.03–1.20)) and all cancers between 1997 and 2001.

While we observed a trend towards reducing differences in survival over time in this group, a contrasting trend was observed for CNS tumours whereby sizeable variation in outcome remained for cases diagnosed until 2012.

South Asian children with lymphoma had a 15% reduced chance of surviving at least 5 years compared to non-south Asian, across the study period.

Discussion Even in the United Kingdom, with a universally accessible healthcare system, socio-economic and ethnic disparities in childhood cancer survival exist.

Findings should inform where resources should be directed to provide all children with an equitable survival outcome following a cancer diagnosis.

Cromie, K. J.,Hughes, N. F.,Milner, S.,Crump, P.,Grinfeld, J.,Jenkins, A.,Norman, P. D.,Picton, S. V.,Stiller, C. A.,Yeomanson, D.,Glaser, A. W.,Feltbower, R. G., 2023, Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK, Nature

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw